Found: 17
Select item for more details and to access through your institution.
PROTAC-mediated CDK degradation differentially impacts cancer cell cycles due to heterogeneity in kinase dependencies.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1238, doi. 10.1038/s41416-023-02399-4
- By:
- Publication type:
- Article
REPRESENT recommendations: improving inclusion and trust in cancer early detection research.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1195, doi. 10.1038/s41416-023-02414-8
- By:
- Publication type:
- Article
Effect of a 1-year physical activity intervention on cardiovascular health in long-term childhood cancer survivors—a randomised controlled trial (SURfit).
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1284, doi. 10.1038/s41416-023-02410-y
- By:
- Publication type:
- Article
Loss of NDUFS1 promotes gastric cancer progression by activating the mitochondrial ROS-HIF1α-FBLN5 signaling pathway.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1261, doi. 10.1038/s41416-023-02409-5
- By:
- Publication type:
- Article
Histological diagnosis of polyploidy discriminates an aggressive subset of hepatocellular carcinomas with poor prognosis.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1251, doi. 10.1038/s41416-023-02408-6
- By:
- Publication type:
- Article
Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1209, doi. 10.1038/s41416-023-02434-4
- By:
- Publication type:
- Article
Correction to: Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Correction: Maternal and childhood medical history and the risk of childhood brain tumours: a case–control study in Ontario, Canada.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1350, doi. 10.1038/s41416-023-02406-8
- By:
- Publication type:
- Article
Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1274, doi. 10.1038/s41416-023-02403-x
- By:
- Publication type:
- Article
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1327, doi. 10.1038/s41416-023-02402-y
- By:
- Publication type:
- Article
Surveillance after childhood cancer: are survivors with an increased risk for cardiomyopathy regularly followed-up?
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1298, doi. 10.1038/s41416-023-02400-0
- By:
- Publication type:
- Article
Synthetic viability induces resistance to immune checkpoint inhibitors in cancer cells.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1339, doi. 10.1038/s41416-023-02404-w
- By:
- Publication type:
- Article
Dissecting the pathogenic effects of smoking and its hallmarks in blood DNA methylation on colorectal cancer risk.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1306, doi. 10.1038/s41416-023-02397-6
- By:
- Publication type:
- Article
Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1314, doi. 10.1038/s41416-023-02396-7
- By:
- Publication type:
- Article
Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1225, doi. 10.1038/s41416-023-02389-6
- By:
- Publication type:
- Article
Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 8, p. 1212, doi. 10.1038/s41416-023-02361-4
- By:
- Publication type:
- Article